Siemens to Reduce Stake in Healthineers to Minority Position -- Update

Dow Jones11-13
 

By Nina Kienle

 

Siemens said it would deconsolidate its roughly 67% stake in Siemens Healthineers, positioning itself as a focused technology company.

The German industrial conglomerate said Wednesday that it plans to transfer 30% of Siemens Healthineers shares to Siemens AG shareholders by way of a spinoff. Cutting its stake in Healthineers will allow the group greater flexibility in allocating capital while maintaining a minority interest in the "attractive business," Siemens said.

Siemens's current stake in Healthineers is worth around 33.9 billion euros ($39.26 billion), according to LSEG data.

In the medium term, Siemens aims to reduce the shareholding to a financial asset, it said.

The spinoff is a further step in simplifying its portfolio, Siemens said.

Siemens listed the medical-equipment unit in 2018, keeping an initial 85% share. It has since then gradually cut its shareholding in the business. Earlier this year it sold 2% for around 1.45 billion euros, taking its stake to 73%. In April, Siemens acquired science-software company Dotmatics for $5.1 billion, financed primarily through the sale of shares in listed companies, including Siemens Healthineers, it said at the time.

"By giving up the controlling majority in Siemens Healthineers, we are focusing on a highly synergistic Siemens portfolio," Siemens Chief Executive Roland Busch said on Wednesday.

"This is a logical next step in executing our strategy of combining the real and the digital worlds, focusing on accelerated profitable growth of our digital businesses, connected and software defined hardware and industrial [artificial intelligence]," Busch said.

The spinoff transaction remains subject to shareholder approval of both companies. Frankfurt-listed Siemens Healthineers will host its capital-markets day on Nov. 17, at which it will outline its midterm strategy and financial targets.

Separately, Siemens said Veronika Bienert will succeed current Chief Financial Officer Ralf Thomas at some point in fiscal 2026, which began Oct. 1.

 

Write to Nina Kienle at nina.kienle@wsj.com

 

(END) Dow Jones Newswires

November 12, 2025 13:59 ET (18:59 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment